Physician profile
Robert Ball
NPI 1841454477
$246,485.63
in general payments reported to CMS, 2019-2025
32 companies · $52K in 2025
The $52K reported for 2025 was more than what 98% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,923 · 2020: $4,279 · 2021: $9,251 · 2022: $42K · 2023: $86K · 2024: $51K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $160K · Food and Beverage: $15K · Travel and Lodging: $12K · Consulting Fee: $1,155 · Entertainment: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $160,246.25 |
| Food and Beverage | $14,599.69 |
| Travel and Lodging | $11,642.85 |
| Consulting Fee | $1,155.00 |
| Entertainment | $310.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $134,688.20 | 2019-2023 | Intracept |
| Boston Scientific Corporation | $96,974.50 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $6,250.46 | 2019-2025 | Proclaim, Eterna |
| Foundation Fusion Solutions, LLC | $2,256.82 | 2024-2025 | |
| Nevro Corp. | $1,078.29 | 2019-2024 | Senza |
| Medtronic USA, INC. | $747.61 | 2019-2020 | |
| Painteq LLC | $737.82 | 2021-2024 | Painteq |
| Medtronic, INC. | $597.49 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Nalu Medical, INC. | $444.41 | 2020-2025 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $406.08 | 2019-2024 | Mild Device Kit |
| Vgi Medical, LLC | $386.58 | 2022 | |
| Vertiflex, INC. | $326.27 | 2019 | |
| Mml US, INC. | $288.05 | 2023-2024 | Reactiv8 |
| Abbvie INC. | $275.85 | 2021-2025 | Botox |
| Stryker Corporation | $213.74 | 2019-2025 | Optablate |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $163.97 | 2019 | |
| Allergan, INC. | $109.67 | 2019-2021 | |
| Curonix LLC | $71.83 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lundbeck LLC | $68.22 | 2024-2025 | Vyepti |
| Spr Therapeutics, INC | $66.15 | 2022-2025 | Sprint Pns System |
| Si-Bone, INC. | $60.69 | 2023-2024 | |
| Merit Medical Systems INC | $53.09 | 2023 | Stabilit |
| Almatica Pharma LLC | $31.55 | 2022-2023 | Gralise |
| Fidia Pharma USA INC. | $28.62 | 2025 | Hymovis, Triluron |
| Averitas Pharma INC. | $26.48 | 2024 | Qutenza |
| Biotronik Nro, INC. | $22.90 | 2025 | Prospera |
| Teva Pharmaceuticals USA, INC. | $22.81 | 2019-2020 | |
| Globus Medical, INC. | $22.71 | 2025 | Senza |
| Pacira Therapeutics, INC. | $22.49 | 2019 | |
| Spinal Simplicity, LLC | $19.06 | 2023 | Ha Minuteman G3-R |
| Avanos Medical | $13.80 | 2019 | |
| Saluda Medical Americas, INC. | $9.42 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.